A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide

Global Journal of Cancer Therapy
Research Article
Background: Despite the crucial role of integrin receptors in cancer pathogenesis and massive efforts towards establishing clinically relevant drugs, to the present no effective integrin antagonist for the treatment of malignant diseases has been introduced into the clinic.
http://www.peertechz.com/Cancer-Therapy/pdf/GJCT-2-108.pdf

Comments

Popular posts from this blog

Case Report: Reynolds Syndrome

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Ministernotomy Thymectomy in Mysthania Gravis-Future